Almaty's Perinatal Center Achieves Zero Maternal Deaths by 2025

Almaty’s City Perinatal Center has achieved a major milestone in maternal healthcare. By the end of 2025, the facility reported zero maternal deaths—a result of advanced treatments and specialised care. One key innovation, the Uterine Hemorrhage Control Balloon, has played a crucial role in reducing severe complications from postpartum bleeding. The center handles around 10,000 deliveries each year, including the most complex cases referred from across Kazakhstan. It also manages over 60% of Almaty’s preterm births, providing critical support for premature infants.

Since 2023, the facility has used uterine balloon tamponade as a second-line treatment for postpartum hemorrhage. The procedure, now part of Kazakhstan’s clinical guidelines, involves inserting a specially designed balloon to control bleeding. This method has proven both effective and cost-efficient, reducing the need for emergency surgeries. The results have been striking. Over the past 2.5 years, the technique has cut life-saving organ-removal surgeries by more than 51%, even in severe cases of blood loss during C-sections. The balloons, produced by local manufacturer Almerek LLP, are provided under the state’s guaranteed free medical care program. Before this intervention, postpartum hemorrhage often required drastic measures. Now, the center’s approach has made such surgeries far less common, improving recovery outcomes for new mothers.

The City Perinatal Center’s success highlights the impact of targeted medical advancements. With zero maternal deaths recorded by late 2025, the facility has set a new standard in obstetric care. The widespread adoption of balloon tamponade, backed by state support, continues to save lives and reduce the need for invasive procedures.